Trial
NCT00400205
Study of Induction Docetaxel, Cisplatin and 5-Fluorouracil
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Emory University
Collaborators
Sanofi
Condition
Squamous Cell Carcinoma
Intervention
Docetaxel
Why stopped
Safety reasons
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-11-06